Table 7 Symptomatic medical treatment for IPF
From: Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Medication | N / % |
|---|---|
Opioids a | 27 / 20.5 |
Oxygen therapy | 45 /34.1 |
Ambulatory | 17 / 37.7 |
Long term | 28 / 21.1 |
Inhaled corticosteroids | 9 / 6.8 |
Short-acting beta-agonists | 7 / 5.3 |
Anticholinergic drugs | 2 / 1.5 |
Theophylline | 1 / 0.8 |
Montelukast | 1 / 0.8 |
Mycolytics | 3 / 2.3 |